Clinical Trial Update: Treatment of Insomnia in Patients With Parkinson's Disease: A Multi-site, Placebo-controlled Study of Eszopiclone [Phase 3]

View source ↗

Summary

Phase 3, multi-site, placebo-controlled trial evaluating eszopiclone for insomnia in patients with Parkinson's disease; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia
• Parkinson Disease

Drugs mentioned

• Lunesta (eszopiclone)

Snippet

Sponsor: University of Medicine and Dentistry of New Jersey | Conditions: Parkinson's Disease, Insomnia | Phase 3 | Status: COMPLETED | Results posted: 2013-05-31